Editorial: CT-P13, a biosimilar of anti-tumour necrosis factor-alpha agent (infliximab), in inflammatory bowel diseases
2017 ◽
Vol 45
(10)
◽
pp. 1370-1371
◽
2018 ◽
Vol 12
(supplement_1)
◽
pp. S034-S035
2014 ◽
Vol 40
(9)
◽
pp. 1035-1043
◽
2015 ◽
Vol 9
(5)
◽
pp. 382-389
◽
2020 ◽
Vol 49
(3)
◽
pp. 317-324
◽
2016 ◽
Vol 10
(suppl 1)
◽
pp. S399.2-S400
2007 ◽
Vol 27
(1)
◽
pp. 19-30
◽